ADVANCED MATERIALS GROUP INC
DEF 14A, 1996-03-29
PLASTICS FOAM PRODUCTS
Previous: FIRST DEARBORN INCOME PROPERTIES LP, 10-K, 1996-03-29
Next: ENEX OIL & GAS INCOME PROGRAM III SERIES 1 L P, 10KSB, 1996-03-29



<PAGE>
                            SCHEDULE 14A INFORMATION
 
                  Proxy Statement Pursuant to Section 14(a) of
            the Securities Exchange Act of 1934 (Amendment No.    )
 
    Filed by the Registrant /X/
    Filed by a Party other than the Registrant / /
 
    Check the appropriate box:
    / /  Preliminary Proxy Statement
    / /  Confidential, for Use of the Commission Only (as permitted by Rule
         14a-6(e)(2))
    /X/  Definitive Proxy Statement
    / /  Definitive Additional Materials
    / /  Soliciting  Material  Pursuant  to  Section  240.14a-11(c)  or  Section
         240.14a-12
 
                        ADVANCED MATERIALS GROUP, INC.
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)
 
- --------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
 
/X/  $125 per  Exchange Act  Rules 0-11(c)(1)(ii),  14a-6(i)(1), 14a-6(i)(2)  or
     Item 22(a)(2) of Schedule 14A.
/ /  $500  per  each party  to  the controversy  pursuant  to Exchange  Act Rule
     14a-6(i)(3).
/ /  Fee  computed  on   table  below   per  Exchange   Act  Rules   14a-6(i)(4)
     and 0-11.
     1) Title of each class of securities to which transaction applies:

        ------------------------------------------------------------------------
     2) Aggregate number of securities to which transaction applies:

        ------------------------------------------------------------------------
     3) Per unit price or other underlying value of transaction computed
        pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
        filing fee is calculated and state how it was determined):

        ------------------------------------------------------------------------
     4) Proposed maximum aggregate value of transaction:

        ------------------------------------------------------------------------
     5) Total fee paid:

        ------------------------------------------------------------------------
/ /  Fee paid previously with preliminary materials.
/ /  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the  filing for which the  offsetting fee was paid
     previously. Identify the previous filing by registration statement  number,
     or the Form or Schedule and the date of its filing.
     1) Amount Previously Paid:

        ------------------------------------------------------------------------
     2) Form, Schedule or Registration Statement No.:

        ------------------------------------------------------------------------
     3) Filing Party:

        ------------------------------------------------------------------------
     4) Date Filed:

        ------------------------------------------------------------------------
<PAGE>
                         ADVANCED MATERIALS GROUP, INC.
                            20211 SOUTH SUSANA ROAD
                       RANCHO DOMINGUEZ, CALIFORNIA 90221
 
                                                                   April 8, 1996
 
To Our Shareholders:
 
    You  are cordially invited to attend the 1995 Annual Meeting of Shareholders
of Advanced Materials Group,  Inc. (the "Company") which  will be held at  10:00
a.m.  on May 8,  1996, at The ANA  Hotel, 2401 M  Street, N.W., Washington, D.C.
20037, in the Culpepper  Room. All holders of  the Company's outstanding  Common
Stock as of March 29, 1996 are entitled to vote at the Annual Meeting.
 
    Enclosed  is a copy of  the Notice of Annual  Meeting of Shareholders, Proxy
Statement and Proxy  Card. A current  report on the  business operations of  the
Company  will  be  presented  at  the  meeting  and  shareholders  will  have an
opportunity to ask questions.
 
    We hope you will be  able to attend the Annual  Meeting. Whether or not  you
expect  to attend, it is important you complete, sign, date and return the proxy
card in the enclosed envelope in order to make certain that your shares will  be
represented at the Annual Meeting.
 
                                          Sincerely,
 
                                          Steve F. Scott
                                          PRESIDENT, CHIEF EXECUTIVE OFFICER AND
                                          SECRETARY
<PAGE>
                         ADVANCED MATERIALS GROUP, INC.
                            20211 SOUTH SUSANA ROAD
                       RANCHO DOMINGUEZ, CALIFORNIA 90221
 
                            ------------------------
 
                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                             TO BE HELD MAY 8, 1996
 
    NOTICE  IS HEREBY GIVEN that the  Annual Meeting of Shareholders of Advanced
Materials Group, Inc.,  a Nevada corporation  (the "Company"), will  be held  at
10:00  a.m. local time,  on May 8, 1996  at The ANA Hotel,  2401 M Street, N.W.,
Washington, D.C. 20037,  in the Culpepper  Room (the "Annual  Meeting") for  the
following purposes:
 
    1.  To elect five directors to the Board of Directors;
 
    2.  To reapprove the Company's 1993 Stock Option Plan; and
 
    3.  To  transact such other business as  may properly come before the Annual
        Meeting or any adjournment or adjournments thereof.
 
    The Board of Directors has fixed the close of business on March 29, 1996, as
the record date for the determination of shareholders entitled to notice of  and
vote at the Annual Meeting and all adjourned meetings thereof.
 
                                          By Order of the Board of Directors
 
                                          Steve F. Scott
                                          PRESIDENT, CHIEF EXECUTIVE OFFICER AND
                                          SECRETARY
 
Dated: April 8, 1996
 
PLEASE  FILL IN, DATE, SIGN AND RETURN THE ENCLOSED PROXY IN THE RETURN ENVELOPE
FURNISHED FOR THAT PURPOSE AS PROMPTLY AS  POSSIBLE, WHETHER OR NOT YOU PLAN  TO
ATTEND  THE ANNUAL  MEETING. IF YOU  LATER DESIRE  TO REVOKE YOUR  PROXY FOR ANY
REASON, YOU MAY DO SO IN THE MANNER DESCRIBED IN THE ATTACHED PROXY STATEMENT.
<PAGE>
                         ADVANCED MATERIALS GROUP, INC.
                            20211 SOUTH SUSANA ROAD
                       RANCHO DOMINGUEZ, CALIFORNIA 90221
 
                            ------------------------
 
                                PROXY STATEMENT
                         ANNUAL MEETING OF SHAREHOLDERS
                             TO BE HELD MAY 8, 1996
 
                            ------------------------
 
                                VOTING AND PROXY
 
    This  Proxy Statement is being furnished in connection with the solicitation
of proxies by  the Board  of Directors of  Advanced Materials  Group, Inc.  (the
"Company")  for use at  the Annual Meeting  of Shareholders to  be held at 10:00
a.m., local  time, on  May 8,  1996,  at The  ANA Hotel,  2401 M  Street,  N.W.,
Washington,  D.C. 20037, in the Culpepper Room (the "Annual Meeting") and at any
adjournments thereof. When  such proxy  is properly executed  and returned,  the
shares  it  represents will  be voted  in accordance  with any  directions noted
thereon.  In  voting  by  proxy  with  regard  to  the  election  of  directors,
stockholders  may vote in favor of all  nominees, withhold their votes as to all
nominees or withhold their  votes as to  specific nominees. Stockholders  should
specify  their choices  on the  accompanying proxy  card. All  properly executed
proxy cards delivered  by stockholders to  the Company and  not revoked will  be
voted  at the  Annual Meeting  in accordance  with the  directions given.  If no
specific instructions are given with regard to the matters to be voted upon, the
shares represented by a signed  proxy card will be  voted "FOR" the election  of
all  directors and to approve the Company's 1993 Stock Option Plan. If any other
matters properly come before  the Annual Meeting, the  persons named as  proxies
will  vote  upon  such  matters  in accordance  with  their  best  judgment. Any
shareholder giving a proxy has the power to  revoke it at any time before it  is
voted  by  written notice  to the  Secretary of  the Company,  by issuance  of a
subsequent proxy or by voting at the Annual Meeting in person.
 
    At the close of business on March 29, 1996, the record date for  determining
shareholders  entitled  to notice  of and  to  vote at  the Annual  Meeting, the
Company had issued and outstanding 10,450,316 shares of Common Stock, par  value
$.001  per share (the "Common  Stock"). Each share of  Common Stock entitles the
holder of record  thereof to one  vote on  any matter coming  before the  Annual
Meeting.  Only shareholders of record at the close of business on March 29, 1996
are entitled  to  notice  of and  to  vote  at  the Annual  Meeting  or  at  any
adjournments thereof.
 
    The presence, in person or by proxy, of a majority of the outstanding shares
of Common Stock of the Company is necessary to constitute a quorum at the Annual
Meeting.  The affirmative vote  of the holders  of a plurality  of the shares of
Common Stock represented in person or by proxy at the Annual Meeting is required
to elect directors, and the affirmative vote of the holders of a majority of the
shares of Common Stock represented in person  or by proxy at the Annual  Meeting
is  required to approve the Company's 1993  Stock Option Plan. These matters are
described in the  following sections  of this Proxy  Statement. Abstentions  and
shares held by a broker in "street name" ("Broker Shares") that are not voted in
the  election of  directors will  not be included  in determining  the number of
votes cast.  Abstentions and  Broker Shares  that  are voted  as to  any  matter
presented at the meeting, but not voted on any particular proposal will have the
same effect as votes cast in opposition to such proposal. Broker Shares that are
not  voted  on any  matter  presented at  the meeting  will  not be  included in
determining the number of shares present or represented at the meeting.
 
    The Company  will pay  the expenses  of soliciting  proxies for  the  Annual
Meeting,  including the  cost of  preparing, assembling,  and mailing  the proxy
solicitation materials. Proxies may  be solicited personally, or  by mail or  by
telephone,   by  directors,  officers  and  regular  employees  of  the  Company
<PAGE>
who will not  be additionally compensated  therefor. Brokerage firms,  nominees,
custodians  and fiduciaries also may be  requested to forward proxy materials to
the beneficial owners of shares held of  record by them. It is anticipated  that
this  proxy statement  and accompanying  proxy card will  be mailed  on or about
April 8, 1996 to all shareholders entitled to vote at the Annual Meeting.
 
         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
    The following  table sets  forth certain  information regarding  the  Common
Stock  beneficially owned as of March 29, 1996,  (i) by each person who is known
by the Company  to own beneficially  or exercise voting  or dispositive  control
over 5% or more of the Common Stock, (ii) by each of the Company's directors and
nominees for director, and (iii) by all officers and directors as a group.
 
<TABLE>
<CAPTION>
NAME AND ADDRESS                           NUMBER OF SHARES      PERCENTAGE OF
OF BENEFICIAL OWNER                       BENEFICIALLY OWNED   OUTSTANDING SHARES
- ----------------------------------------  ------------------   ------------------
<S>                                       <C>                  <C>
Trilon Dominion Partners, L.L.C.             4,565,807(1)              40%
14120 Chepstow Road
Midlothian, VA 23113
 
Director/Nominees:
 
William J. Hopke                                30,000(2)              *
Trilon Dominion Partners
14120 Chepstow Road
Midlothian, VA 23113
 
Steve F. Scott                                 200,000(3)             1.9%
20211 South Susana Road
Rancho Dominguez, California 90221
 
Michael A. Ledeen                               70,000(4)              *
7312 Western Avenue
Chevy Chase, Maryland 20815
 
N. Price Paschall                              190,000(5)             1.8%
One Penn Plaza, Suite 2134
New York, New York 10119
 
Allan H. Meltzer                                31,000(6)              *
GSIA Carnegie-Mellon University
Schenley Park
Pittsburgh, Pennsylvania 15213
 
All officers and directors as a group (6       521,000(7)
  persons)                                                            4.8%
</TABLE>
 
- ------------------------
*   Less than 1%.
 
(1) Includes  965,000  shares issuable  upon the  exercise  of warrants  held by
    Trilon Dominion Partners, L.L.C. (Trilon) which are presently exercisable or
    exercisable within 60 days of March 29, 1996.
 
(2) Comprised of 30,000  shares which Mr.  Hopke has the  right to acquire  upon
    exercise  of stock  options presently  exercisable or  exercisable within 60
    days of March 29, 1996.
 
(3) Comprised of 200,000 shares  which Mr. Scott has  the right to acquire  upon
    exercise  of stock  options presently  exercisable or  exercisable within 60
    days of March 29, 1996.
 
(4) Includes 10,000  shares which  Mr. Ledeen  owns jointly  with his  wife  and
    20,000  shares which Mr.  Ledeen has the  right to acquire  upon exercise of
    stock options presently exercisable or  exercisable within 60 days of  March
    29, 1996.
 
                                       2
<PAGE>
(5) Comprised of 190,000 shares which Mr. Paschall has the right to acquire upon
    exercise  of options presently exercisable or  exercisable within 60 days of
    March 29, 1996.
 
(6) Includes 30,000  shares which  Mr. Meltzer  has the  right to  acquire  upon
    exercise  of options presently exercisable or  exercisable within 60 days of
    March 29, 1996.
 
(7) Includes an  aggregate of  470,000 shares  issuable upon  exercise of  stock
    options  presently exercisable  or exercisable within  60 days  of March 29,
    1996 held by such officers and  directors. Does not include shares owned  by
    Trilon; Mr. Hopke is Chief Operating Officer of Trilon.
 
CHANGE IN CONTROL
 
    In  a transaction reported on  a Schedule 13D filed  with the Securities and
Exchange Commission ("SEC") by Dominion Resources, Inc. ("Dominion  Resources"),
Dominion  Capital, Inc.  ("Dominion Capital"), VC  Holdings, Inc.  and Ronald W.
Cantwell dated  June 30,  1995, Dominion  Capital contributed  its ownership  of
Common  Stock of the Company, including warrants  to acquire Common Stock of the
Company and a line  of credit, to  Trilon in exchange for  a non-voting Class  B
membership  interest in Trilon. The Operating  Agreement for Trilon, dated as of
June 30, 1995, provides  that Trilon may  not sell the  shares of the  Company's
Common  Stock  contributed by  Dominion Capital  for less  than the  agreed fair
market value of such shares at the time of their contribution without (except in
certain limited  circumstances)  the consent  of  Dominion Capital.  William  J.
Hopke,  Chairman of the  Company's Board of Directors,  was formerly Senior Vice
President and Treasurer of Dominion Capital  and is now Chief Operating  Officer
of Trilon.
 
    Subsequently,  pursuant  to  a  Subscription  and  Investment Representation
Agreement dated December 22, 1995,  Trilon purchased from the Company  1,260,807
newly  issued shares of the Company's Common  Stock, plus warrants to acquire an
additional 30,000 shares  of Common Stock,  for an aggregate  purchase price  of
$700,000 in cash.
 
    Also  effective as of  December 22, 1995,  Trilon increased the  amount of a
line of credit to the Company from  $700,000 to $1,000,000, with an increase  in
the  interest rate to  5% over the  prime rate, and  in connection therewith was
granted a warrant to  acquire 60,000 shares  of Common Stock,  and a warrant  to
acquire  30,000 shares of Common Stock, exercisable in the event of a failure to
pay the principal amount of the line of credit on or before June 30, 1997, at an
exercise price equal to the fair market value of the Common Stock at such time.
 
    After the transactions described herein, Trilon beneficially owns  3,600,807
shares  of  Company's  Common  Stock (4,595,807  assuming  exercise  of  all the
warrants). Such shares of Common Stock represent 34.5% of the outstanding shares
of Common  Stock of  the Company  (40%  assuming exercise  of all  the  Warrants
exercisable within 60 days of March 29, 1996).
 
    The  matters  to be  considered and  acted  upon at  the Annual  Meeting are
referred to in the preceding notice and are more fully discussed below.
 
                             ELECTION OF DIRECTORS
                                  (PROPOSAL 1)
 
    Directors are elected annually and hold office until the next annual meeting
of shareholders  or until  their  respective successors  are elected  and  shall
qualify.  It is intended that the proxies  solicited the Board of Directors will
be voted  for election  of the  five  nominees listed  below unless  a  contrary
instruction  is  made on  the proxy.  If for  any  reason one  or more  of these
nominees should be unavailable  as a candidate for  director, an event which  is
not  anticipated,  the persons  named in  the accompanying  proxy will  vote for
another candidate or candidates nominated by the Board of Directors.
 
    All of the nominees for director are, at present, directors of the Company.
 
    THE COMPANY RECOMMENDS THAT  STOCKHOLDERS VOTE "FOR"  THE PROPOSAL TO  ELECT
ALL FIVE NOMINEES LISTED BELOW A DIRECTOR OF THE COMPANY.
 
                                       3
<PAGE>
    WILLIAM  J. HOPKE, 40, was elected to the Company's Board in April, 1994 and
was made Chairman in July, 1994. Mr.  Hopke has been Chief Operating Officer  of
Trilon  since August,  1995. Previously, he  had been Senior  Vice President and
Treasurer of  Dominion  Capital  since  June,  1993.  Dominion  Capital  is  the
financial  services subsidiary of Dominion Resources,  a New York Stock Exchange
listed  holding  company  with  interests  in  an  electric  utility  and  other
energy-related  businesses.  Mr.  Hopke  joined Dominion  Resources  in  1985 as
director of financial services and has  held various positions in both  Dominion
Resources  and Dominion Capital since such date. He also serves as a director of
Wilshire Technologies, Inc. ("WTI") and as a director of Organogenesis, Inc. Mr.
Hopke holds  a bachelor's  degree in  business administration  from  Christopher
Newport College.
 
    STEVE  F. SCOTT, 51,  has been President  and Director of  the Company since
June, 1991, and was appointed Chief Executive Officer in July, 1994. He has been
with the Company and its predecessors for a total of nearly 13 years,  including
previous  positions as  General Manager and  Vice President of  Sales. Mr. Scott
returned to the Company in June, 1991  at the request of the Board of  Directors
to  complete the management and financial  turnaround of the business. Mr. Scott
was President of  Pleuss-Staufer, a  Swiss based  mining company,  from 1989  to
1991.  Mr.  Scott has  a B.S.  in  Chemical Engineering  from the  University of
Cincinnati and an MBA from California State University of Long Beach.
 
    N. PRICE PASCHALL, 47,  was elected to the  Company's Board of Directors  in
January,  1994.  Mr. Paschall  has been  President of  Paschall and  Company, an
investment banking  firm  that serves  clients  in the  medical  and  industrial
markets,  since February,  1992. Mr. Paschall  was a partner  of Shea, Paschall,
Powell-Hambros Bank,  a  firm specializing  in  mergers and  acquisitions,  from
August,  1987  to  January,  1992.  Mr.  Paschall  holds  a  degree  in Business
Administration from California Polytechnic University in Pomona.
 
    DR. MICHAEL LEDEEN, 54, was elected  to the Company's Board of Directors  in
June,  1993. Dr. Ledeen, a Resident Scholar at the American Enterprise Institute
in Washington,  D.C.,  since 1989  and  a Senior  Advisor  at Bear  Stearns,  an
investment  banking  firm, since  May,  1993, is  an  expert in  foreign policy,
intelligence, and  international  business. The  author  of a  dozen  books  and
hundreds  of articles on twentieth-century history, Dr. Ledeen served as Special
Advisor to  Secretary  of State  Alexander  Haig, and  as  a consultant  to  the
National  Security  Council during  the Reagan  presidency.  The founder  of the
Washington Quarterly, Dr. Ledeen writes regularly for the American Spectator and
Commentary. He  holds  a Ph.D.  in  European  History and  Philosophy  from  the
University of Wisconsin, and a B.A. from Pomona College.
 
    DR. ALLAN H. MELTZER, 68, was elected to the Company's Board of Directors in
July,  1994.  Dr. Meltzer  has been  a  Professor at  the Carnegie  Institute of
Technology, Graduate School  of Industrial  Administration, since  1964. He  has
been  a  director of  Cooper Tire  & Rubber  since  1984, has  held a  number of
visiting and honorary teaching  posts, and has been  a member of several  policy
advisory  boards  and committees.  He received  an A.B.  in economics  from Duke
University in 1948, and an M.A. in economics in 1955 and a Ph.D. in economics in
1958 from the University of California, Los Angeles.
 
    Following  is  information  regarding  J.  Douglas  Graven,  who  has   been
appointed, effective February 1, 1996, as the Company's Chief Financial Officer.
Mr. Graven is not a nominee for director.
 
    J.  DOUGLAS  GRAVEN, 40,  was  appointed Chief  Financial  Officer effective
February,  1996.  From  August,  1994,  to  February,  1996,  he  was  Corporate
Controller  for  Milhous  Group,  a  privately  held  holding  company  for four
operating subsidiaries, and  from March, 1991  to April, 1994,  he was  Manager,
Corporate Accounting for Nissan Motor Corporation in U.S.A., Inc.
 
    All   directors  are  entitled   to  receive  $500   and  reimbursement  for
out-of-pocket expenses in connection  with their attendance  at meetings of  the
Board    of    Directors.    In   addition,    each    director    is   entitled
 
                                       4
<PAGE>
to receive non-qualified  stock options,  pursuant to the  Company's 1993  Stock
Option  Plan, to purchase  20,000 shares of  the Company's Common  Stock at fair
market value when elected  to the Board,  and 10,000 shares  of Common Stock  at
fair market value on each anniversary of the date of his election to the Board.
 
BOARD OF DIRECTORS MEETINGS
 
    The  Board of Directors  of the Company  held one meeting  during the fiscal
year ended November 30, 1995.  No Director attended less  than 75% of the  total
number  of meetings of the Board of Directors  and of all committees of which he
was a  member. The  Board  does not  have an  audit  committee or  a  nominating
committee. The Board has a compensation committee comprised of Messrs. Paschall,
Ledeen and Meltzer. The committee will evaluate the performance of the Company's
officers,  and make  recommendations to  the Board  concerning compensation. The
committee will also determine option grants pursuant to the Company's 1993 Stock
Option Plan. The committee held no meetings in fiscal 1995.
 
COMPLIANCE WITH SECTION 16(A)
 
    Section 16(a) of the Securities Exchange Act of 1934 requires the  Company's
directors  and executive officers,  and any persons  who own more  than 10% of a
registered class of the Company's equity securities to file with the SEC reports
of ownership  and  changes  in  ownership  of  Common  Stock  and  other  equity
securities of the Company. Officers, directors and greater than 10% shareholders
are required by SEC regulation to furnish the Company with copies of all Section
16(a)  forms they  file. Based solely  on review  of the copies  of such reports
furnished to the Company or written  representations that no other reports  were
required, the Company believes that, during fiscal 1995, all filing requirements
applicable  to its  officers, directors and  greater than  10% beneficial owners
were complied with, except that each of the directors was late in filing a  Form
5  report at  the end  of fiscal  1995. Such  reports have  now been  filed with
respect to all the directors except Mr.  Hopke, and included in such reports  is
disclosure  correcting delinquencies from previous fiscal years. The Company has
implemented a  program to  enhance  compliance by  directors and  officers  with
future  Section 16(a) reporting  obligations. The implementation  of the program
was delayed  in  fiscal 1995  due  to the  resignation  of the  Company's  Chief
Financial  Officer and, in January, 1996,  the Company's Controller. A new Chief
Financial Officer, J. Douglas  Graven, was retained in  February, 1996, and  has
assumed responsibility for the Company's Section 16(a) compliance program.
 
                             EXECUTIVE COMPENSATION
 
    The  following  table  sets  forth  certain  summary  information  regarding
compensation paid by the Company for  services rendered during the fiscal  years
ended  November 30,  1993, 1994 and  1995, respectively, to  the Company's Chief
Executive Officer during such period. No other executive officer of the  Company
holding  office in fiscal 1995 received  total annual salary and bonus exceeding
$100,000.
 
                           SUMMARY COMPENSATION TABLE
 
<TABLE>
<CAPTION>
                                                                                                  LONG-TERM
                                                                                                 COMPENSATION
                                                                                                    AWARDS
                                                                                                 ------------
                                                                     ANNUAL COMPENSATION          SECURITIES
                                                               -------------------------------    UNDERLYING
                                                YEAR ENDING                       OTHER ANNUAL     OPTIONS/
            NAME AND PRINCIPAL POSITION         NOVEMBER 30,    SALARY    BONUS   COMPENSATION     SARS (#)
      ----------------------------------------  ------------   --------  -------  ------------   ------------
      <S>                                       <C>            <C>       <C>      <C>            <C>
      Steve F. Scott,                               1993       $123,775       --   $9,000(2)      180,000(3)
       President and Chief Executive Officer        1994       $123,008       --   $9,000(2)       10,000(3)
       (1)                                          1995       $137,495       --   $9,000(2)       10,000(3)
</TABLE>
 
- ------------------------
(1) Mr. Scott was appointed Chief Executive Officer on July 6, 1994.
 
                                       5
<PAGE>
(2) Includes an allowance for automobile expenses. Does not include an allowance
    for medical  insurance, which  had  aggregated $6,000  over the  three  year
    period immediately prior to the end of fiscal 1995.
 
(3) Options to purchase 160,000 shares at a price of $.30 per share were granted
    to  Mr. Scott under the Company's 1993  Stock Option Plan in connection with
    the reverse acquisition by the Company of Advanced Materials, Inc. ("AM") on
    April 21, 1993, and  were granted in exchange  for the surrender of  options
    held  by Mr. Scott to purchase a like number of shares of Common Stock of AM
    exercisable at a price  of $.30 per  share which had been  granted by AM  on
    December 10, 1992. Options to purchase 20,000 shares at a price of $1.50 per
    share  were granted to Mr. Scott in  fiscal 1993, options to purchase 10,000
    shares at a price  of $2.63 per  share were granted to  Mr. Scott in  fiscal
    1994, and options to purchase 10,000 shares at a price of $0.44 were granted
    to  Mr. Scott in  fiscal 1995, in  each case under  the Company's 1993 Stock
    Option Plan for services as a director.
 
              OPTION GRANTS IN FISCAL YEAR ENDED NOVEMBER 30, 1995
                               INDIVIDUAL GRANTS
 
<TABLE>
<CAPTION>
                                                             PERCENT OF
                                                            TOTAL OPTIONS   EXERCISE
                                                NUMBER OF    GRANTED TO     OR BASE
                                                 OPTIONS    EMPLOYEES IN     PRICE     EXPIRATION
                        NAME                     GRANTED        1995        ($/SH.)       DATE
      ----------------------------------------  ---------   -------------   --------   ----------
      <S>                                       <C>         <C>             <C>        <C>
      Steve F. Scott                            10,000(1)        25%          $.44      5/30/2000
</TABLE>
 
- ------------------------
(1) The options were  automatically granted  in June,  1995, for  services as  a
    director  pursuant to  the Company's  1993 Stock  Option Plan.  The exercise
    price of such options was based upon the average of the bid and asked prices
    as reported by NASDAQ for the date of grant.
 
    No executive officer named in the Summary Compensation Table above exercised
stock options during  the fiscal  year ended  November 30,  1995. The  following
table  sets  forth for  each  person the  fiscal  year-end value  of unexercised
options:
 
                         AGGREGATED OPTION EXERCISES IN
             FISCAL YEAR ENDED NOVEMBER 30, 1995 AND OPTION VALUES
 
<TABLE>
<CAPTION>
                                                                                                       VALUE OF UNEXERCISED
                                                                       NUMBER OF UNEXERCISED           IN-THE MONEY OPTIONS
                                             SHARES                     OPTIONS AT 11/30/95              AT 11/30/95 (1)
                                           ACQUIRED ON    VALUE     ----------------------------   ----------------------------
                     NAME                   EXERCISE     REALIZED   EXERCISABLE   UNEXERCISABLE    EXERCISABLE   UNEXERCISABLE
      -----------------------------------  -----------   --------   -----------   --------------   -----------   --------------
      <S>                                  <C>           <C>        <C>           <C>              <C>           <C>
      Steve F. Scott                            0         --          200,000            0           $75,100            0
</TABLE>
 
- ------------------------
(1) The value of the Company's Common Stock for purposes of the calculation  was
    based  upon the average of the bid and  asked prices for the Common Stock on
    November 30, 1995 as reported by NASDAQ, minus the exercise price.
 
STOCK OPTION PLAN
 
    In 1993, the Company  adopted, and the Company's  stockholders at that  time
approved,  the  Advanced Materials  Group, Inc.  1993  Stock Option  Plan ("1993
Plan") initially providing for the grant  by the Company of options to  purchase
1,250,000  shares of the Company's  Common Stock. At March  29, 1996, options to
purchase 525,000 shares were outstanding at a weighted average exercise price of
$0.842 per  share, and  220,000 options  had been  exercised. The  1993 Plan  is
further described below under "Reapproval of 1993 Stock Option Plan."
 
401(K) PLAN
 
    In  October, 1993, the Company adopted a 401(k) retirement plan, under which
eligible employees  may  contribute,  on a  pre-tax  basis,  up to  15%  of  the
employee's total annual income from the
 
                                       6
<PAGE>
Company,  including bonuses, but  not to exceed  the statutory prescribed annual
limit. All  of  these contributions  are  fully  vested. The  Company  does  not
currently make additional contributions under the plan.
 
LIMITATION ON DIRECTOR'S LIABILITIES UNDER NEVADA LAW
 
    The  Company's  Bylaws  include  provisions to  indemnify  its  officers and
directors and other persons against expenses, judgments, fines and amounts  paid
in settlement in connection with threatened, pending or completed actions, suits
or  proceedings against such  persons by reason  of serving or  having served as
officers, directors or in other capacities,  except in relation to matters  with
respect  to which  such persons shall  be determined  to have acted  not in good
faith, unlawfully or not in the best interest of the Company; provided, however,
that in the case of a suit or proceeding by or in the right of the Company, such
persons shall  be  indemnified only  to  the  extent of  expenses  actually  and
reasonably incurred by them in connection with the defense or settlement thereof
and no indemnification shall be made in respect of any claim, issue or matter as
to  which such  person shall  have been  adjudged to  be liable  to the Company,
unless and only to  the extent that  the court in which  such corporate suit  or
proceeding  was  pending  shall  determine upon  application  that,  despite the
adjudication of liability but in view of all the circumstances of the case, such
person is fairly and  reasonably entitled to indemnity  for such expenses  which
the  court  shall deem  proper.  The Company  has  also obtained  directors' and
officers' liability insurance in the amount of $2,000,000.
 
    Insofar as indemnification for liabilities arising under the Securities  Act
of 1933 (the "Securities Act") may be permitted to directors and officers of the
Company pursuant to the foregoing provisions, or otherwise, the Company has been
advised  that in the opinion  of the SEC such  indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable.
 
                 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 
    In December 1992, AM entered into a one year employment agreement,  approved
by  AM's  Board of  Directors,  with Michael  W.  Crow, former  Chairman  of the
Company, pursuant to which Mr. Crow was entitled to receive annual  compensation
of  $100,000, a monthly car allowance of  $1,000 and a bonus based upon mutually
acceptable performance  criteria  in  an  amount  determined  by  the  Board  of
Directors.  AM also agreed to  pay the premiums on  a term life insurance policy
providing for  death benefits  in  the amount  of  $1,000,000 to  a  beneficiary
designated  by Mr. Crow.  The agreement was terminated  by mutual agreement with
Mr. Crow in July, 1994, at which  time the Company paid an aggregate of  $33,333
to  Mr.  Crow in  settlement  of any  claims  Mr. Crow  may  have had  under the
agreement. Mr. Crow resigned as Chairman of the Company in July, 1994.
 
    The Company entered into a consulting  agreement with Dr. Michael Ledeen  on
June 7, 1993, pursuant to which Dr. Ledeen agreed to consult with the Company on
such  matters as may be requested by the  Company, and the Company agreed to pay
consulting fees of $5,000 per year and granted Dr. Ledeen an option to  purchase
20,000  shares of Common  Stock at a price  of $1.50 per share.  The term of the
consulting agreement was one year (and was extended for one year) unless earlier
terminated by the Company for cause (as defined in the consulting agreement)  or
by  mutual agreement. The exercise  price of such options  was determined by the
Company's Board of  Directors to  be the  fair market value  of a  share of  the
Company's  Common Stock, as to which there was then no public market, based upon
the price at which shares of stock of  AM had previously been sold in a  private
offering in March, 1993.
 
    The Company entered into a consulting agreement with Paschall and Company on
June  1, 1993, pursuant to which Paschall and Company agreed to consult with the
Company regarding significant business acquisitions and other matters  requested
by  the Company, and the  Company agreed to pay  Paschall and Company consulting
fees of $1,000 per month initially, which was increased to $2,500 per month as a
result of the  closing of  the acquisition of  WTI's Medical  OEM division,  and
granted  Paschall  and Company  options to  purchase  100,000 shares  and 40,000
shares, respectively, of Common Stock at  an exercise price of $1.50 per  share.
The    option   to    purchase   40,000    shares   is    fully   vested   while
 
                                       7
<PAGE>
the option  to purchase  100,000 shares  vested  ratably over  the term  of  the
consulting  agreement. The term of the consulting agreement was 18 months unless
earlier terminated  by the  Company  for cause  (as  defined in  the  consulting
agreement)  or by  mutual agreement  or in  the event  Price Paschall  ceased to
control Paschall and Company. The exercise price of such options was  determined
by  the Company's Board of Directors  to be the fair market  value of a share of
the Company's Common Stock, as to which  there was then no public market,  based
upon  the price at  which shares of  stock of AM  had previously been  sold in a
private offering in March, 1993.
 
    On November 23, 1993, AM purchased from WTI, of which Michael W. Crow was an
officer, director and shareholder certain  assets of WTI's OEM Medical  Products
Division  that had been used in  connection with the private label manufacturing
of products  for  medical  accounts.  These  products  included  electrosurgical
grounding  pads,  sponges,  neck  braces, knee  pads  and  other  specialty foam
products. Many of these products were being  manufactured by AM for sale to  WTI
and  ultimate  resale to  a medical  account. The  aggregate purchase  price was
$2,300,000, and AM further assumed liabilities on certain executory contracts in
the approximate amount of $21,000. The consideration  was paid in the form of  a
secured  note in the principal  amount of $1,550,000, payable  45 days after the
closing,  and  the  amendment  and  restatement  of  AM's  secured  subordinated
promissory  note to WTI to increase the principal amount thereof from $1,000,000
to $1,750,000. AM  also agreed  to purchase  related finished  goods, tools  and
drawings  for an  aggregate purchase price  of $555,000. The  purchase price was
based on a percentage of WTI's projected sales in fiscal year 1994 derived  from
the assets sold to AM. The transaction was approved by the disinterested members
of  the Company's Board of Directors, and a fairness opinion with respect to the
transaction was  received by  WTI from  an  independent firm.  AM has  paid  its
$1,550,000  note to WTI in  full. AM borrowed $787,618 of  the funds used to pay
AM's $1,550,000 note to WTI from Mr. Crow. Such loan is further described below.
 
    On January  10,  1994  the  Company  entered  into  a  one  year  employment
agreement,  approved  by the  Company's Board  of  Directors, with  George Pache
pursuant to  which Mr.  Pache was  entitled to  receive annual  compensation  of
$125,000,  a $500 monthly car  allowance and a bonus  based upon mutually agreed
upon performance criteria.  On January 10,  1994, the Company  also granted  Mr.
Pache  an option to purchase 200,000 shares of  Common Stock at a price of $3.75
per share, the market value of a  share of the Company's Common Stock as  quoted
on  NASDAQ on such date,  under its 1993 Stock  Option Plan. After the agreement
expired Mr. Pache continued to serve pursuant to an informal arrangement at  the
same  compensation until March 3,  1995, at which time  he resigned his position
with the Company. At  the time of  his resignation, 38,095  of such options  had
vested, but such options have since expired.
 
    In  March,  1994,  Michael W.  Crow  sold  1,500,000 of  his  shares  of the
Company's Common Stock to Dominion Capital.  On March 25, 1994, Michael W.  Crow
used  $787,618 of the proceeds from the sale of his stock to Dominion Capital to
make a loan to  the Company. The proceeds  of the loan were  used to repay  AM's
$1,550,000  note  to WTI.  The  loan was  evidenced  by the  Company's unsecured
promissory note which provided for payment of interest only on a quarterly basis
at a rate of 1% in excess of a  bank's prime rate until March 25, 1997 when  the
note  was  due and  payable,  provided that  the  Company was  required  to make
principal payments prior  to the due  date at a  rate of 50%  of all new  equity
financing  in excess of the  first $1,000,000 received by  the Company after the
date of the note. As of August 31, 1994, the note was cancelled and reissued  in
equal  amounts  to  each of  Sandra  Crow  (Mr. Crow's  former  spouse)  and The
Peninsula Group Trust, a grantor trust of which Mr. Crow is a beneficiary.
 
    In the opinion of management, all  transactions between the Company and  its
officers,  directors, principal  shareholders or  other affiliates  have been on
terms no less favorable to the Company than could be obtained from  unaffiliated
third parties.
 
                                       8
<PAGE>
                      REAPPROVAL OF 1993 STOCK OPTION PLAN
                                  (PROPOSAL 2)
 
STOCK OPTION PLAN
 
    In  1993, the Company's  Board of Directors  adopted, subject to shareholder
approval, the Advanced Materials Group,  Inc. 1993 Plan initially providing  for
the  grant  by  the Company  of  options  to purchase  1,250,000  shares  of the
Company's Common Stock. At  March 29, 1996, options  to purchase 525,000  shares
were  outstanding at a weighted average exercise  price of $0.842 per share, and
220,000 options had been exercised. At March  27, 1996, the closing bid and  ask
prices  of the  Company's Common  Stock, as reported  by NASDAQ,  were $9/16 and
$9/32, respectively. The  1993 Stock  Option Plan  was approved  by the  written
consent  of  the  Company's  shareholders  on April  21,  1993.  The  Company is
resubmitting the 1993 Plan for  reapproval at this time  in light of changes  in
the Company's ownership since the date of original shareholder approval.
 
    The Board intends to cause the shares of Common Stock to be issued under the
1993 Plan in the future to be registered on a Form S-8 Registration Statement to
be  filed with the  SEC (and, if  deemed appropriate under  the circumstances, a
separate prospectus for the resale of such shares of Common Stock by  affiliates
of  the Company also will  be filed) at the  Company's expense. Prior grants and
exercises of  options  under  the  1993 Plan  have  been  effected  pursuant  to
exemptions  from registration provided by Section  4(2) of the Securities Act of
1933 and/or Regulation D promulgated by the SEC.
 
    All officers (including officers who are members of the Board of Directors),
other  key  employees,  non-employee  directors  and  non-employee   consultants
(including  non-employee consultants who are members  of the Board of Directors)
of the Company or its subsidiaries are eligible to receive options. As of  March
29,  1996, approximately    officers, key  employees, non-employee directors and
non-employee consultants of the Company were eligible to participate in the 1993
Plan.
 
    The text of the 1993 Plan is set forth in its entirety as Exhibit A to  this
Proxy  Statement. The  following summary  of the  1993 Plan  is subject  to, and
qualified in its entirety by reference to, Exhibit A.
 
    The 1993 Plan provides for the grant  by the Company of options to  purchase
shares  of the Company's Common Stock  to its officers, directors, employees and
consultants. The 1993 Plan provides that it is to be administered by a committee
appointed by the Board of Directors (the "Committee") who are "disinterested" as
such term is defined under Rule 16b-3 of the Securities Exchange Act of 1934, as
amended. The Committee has discretion, subject to the terms of the 1993 Plan, to
select the persons entitled  to receive options under  the 1993 Plan, the  terms
and conditions on which options are granted, the exercise price, the time period
for  vesting such shares and the number  of shares subject thereto. In addition,
each director receives  non-qualified stock  options to purchase  20,000 of  the
Company's Common Stock at fair market value on the date of grant when elected to
the  Board, and  non-qualified stock options  to purchase 10,000  shares of fair
market value on the date of grant on each anniversary of his election.
 
    Options granted under the 1993 Plan may be either "incentive stock options,"
within  the  meaning  of   Section  422  of  the   Internal  Revenue  Code,   or
"non-qualified  stock options"  as determined  by the  Committee at  the time of
grant. No incentive stock  option may be  granted to any  person who owns  stock
possessing  more than  10% of the  combined voting  power of all  classes of the
Company's stock or of its parent ("10% Stockholders") unless the exercise  price
is at least equal to 110% of fair market value on the date of grant. Options may
be granted under the 1993 Plan for terms of up to 10 years, except for incentive
stock options granted to 10% Stockholders which are limited to 5-year terms. The
exercise  price in the  case of incentive  stock options granted  under the 1993
Plan must be at least equal to the  fair market value of the Common Stock as  of
the  date of  grant. No incentive  stock options  may be granted  to an optionee
under the 1993 Plan if the aggregate  fair market value (determined on the  date
of  grant)  of the  stock  with respect  to  which incentive  stock  options are
exercisable by such optionee in  any calendar year under  all such plans of  the
Company and its affiliates exceeds $100,000.
 
                                       9
<PAGE>
    Common Stock purchased upon the exercise of options shall be paid for by the
optionee  in cash, or at the discretion of the Committee, by the transfer to the
Company by the optionee of shares of Common Stock which are already owned by the
optionee having a fair market value at the time of exercise equal to the  option
price.
 
    Options  become exercisable  at such times  and in such  installments as the
Committee shall provide in the terms of the individual option agreements.
 
    Options are not transferable by the optionee other than by will or the  laws
of descent and distribution or pursuant to a qualified domestic relations order.
Options are exercisable during the optionee's lifetime only by such optionee or,
in  the  event  of  such optionee's  disability,  by  such  optionee's guardian,
conservator or other legal representative.
 
    The Committee must make adjustments in the option price and in the number or
kind of  shares of  Common  Stock or  other  securities covered  by  outstanding
options  in the event the outstanding Common Stock is increased or decreased, or
changed into or  exchanged for a  different number  or kind of  shares or  other
securities   of  the  Company  or  of   another  corporation,  by  reason  of  a
recapitalization, reclassification, reorganization, merger, consolidation, share
exchange, or other business  combination in which the  Company is the  surviving
parent  corporation, stock split-up, combination of shares, or dividend or other
distribution payable in capital stock or rights to acquire capital stock.
 
    The Board may, from time to time,  make such changes in or additions to  the
1993 Plan as it may deem proper and in the best interests of the Company and its
stockholders. The Board may also suspend or terminate the 1993 Plan at any time,
without  notice, and in its sole discretion.  No such change, however, shall (i)
materially impair any option previously granted under the 1993 Plan without  the
express  written consent of the optionee; or (ii) materially increase the number
of shares subject to the 1993 Plan, materially increase the benefits accruing to
optionees under  the  1993  Plan,  materially  modify  the  requirements  as  to
eligibility  to participate in the 1993 Plan  or alter the method of determining
the option exercise price, without stockholder approval.
 
FEDERAL INCOME TAX CONSEQUENCES
 
    NQOs and Director NQOs
 
    Holders of NQOs and  Director NQOs do  not realize income as  a result of  a
grant  of the option, but normally  realize compensation income upon exercise of
an NQO or Director NQO to the extent that the fair market value of the shares of
Common Stock on  the date of  exercise of the  NQO or Director  NQO exceeds  the
exercise  price paid. The Company will be required to withhold taxes on ordinary
income realized by an optionee upon the exercise of a NQO or Director NQO.
 
    In the case  of an optionee  subject to the  "short-swing" profit  recapture
provisions  of Section 16(b)  of the Exchange Act,  the optionee realizes income
only upon the  lapse of  the six-month period  under Section  16(b), unless  the
optionee elects to recognize income immediately upon exercise of his option.
 
    ISOs.
 
    Holders  of ISOs will not be considered to have received taxable income upon
either the grant of the option or  its exercise. Upon the sale or other  taxable
disposition of the shares, long-term capital gain will normally be recognized on
the  full amount of  the difference between  the amount realized  and the option
exercise price  paid if  no disposition  of the  shares has  taken place  within
either  (a) two years from the date of grant  of the option or (b) one year from
the date of transfer of the shares to the optionee upon exercise. If the  shares
are  sold or otherwise  disposed of before  the end of  the one-year or two-year
periods, the holder of the ISO must include the gain realized as ordinary income
to the extent of  the lesser of (1)  the fair market value  of the option  stock
minus  the option price, or (2) the  amount realized minus the option price. Any
gain  in   excess   of  these   amounts,   presumably,  will   be   treated   as
 
                                       10
<PAGE>
capital  gain. The Company will  be entitled to a tax  deduction in regard to an
incentive stock option only to the extent the optionee has ordinary income  upon
the sale or other disposition of the option shares.
 
    Upon the exercise of an incentive stock option, the amount by which the fair
market  value of the purchased shares at the time of exercise exceeds the option
price will  be  an  "item of  tax  preference"  for purposes  of  computing  the
optionee's  alternative minimum tax for  the year of exercise.  If the shares so
acquired are disposed  of prior to  the expiration of  the one-year or  two-year
periods  described above,  there should be  no "item of  tax preference" arising
from the option exercise.
 
STOCK OPTION GRANTS
 
    The table below indicates grants of  options which were made under the  1993
Plan  after such plan was  adopted by the Board of  Directors. All of the grants
identified below were nonstatutory  options. Future awards  under the 1993  Plan
are  not yet determinable, except for automatic grants to directors as described
above.
 
                                 PLAN BENEFITS
 
<TABLE>
<CAPTION>
                                                   NUMBER OF
                                                  SECURITIES
                                                  UNDERLYING      EXERCISE    EXPIRATION
      NAME AND POSITION                         OPTIONS GRANTED   PRICE (1)      DATE
      ----------------------------------------  ---------------   ---------   ----------
      <S>                                       <C>               <C>         <C>
      Steve F. Scott (2)......................      160,000         $ .30        4/20/98
        President, Chief Executive                   20,000         $1.50        5/31/98
        Officer and Director                         10,000         $2.63        5/31/99
                                                     10,000         $ .44        5/31/00
 
      William J. Hopke (2)....................       20,000         $2.22        4/21/99
        Chairman                                     10,000         $ .48        4/21/00
 
      Allan H. Meltzer (2)....................       20,000         $1.63         7/4/99
        Director                                     10,000         $ .52         7/4/00
 
      N. Price Paschall (2)...................       20,000         $4.00        1/25/99
        Director                                     10,000         $ .59        1/25/00
                                                     10,000         $ .69        1/25/01
 
      Michael A. Ledeen (2)...................       20,000         $1.50         6/7/98
        Director                                     10,000         $2.16         6/7/99
                                                     10,000         $ .40         6/7/00
</TABLE>
 
- ------------------------
(1) All such options were granted at fair market value as at the date of grant.
 
(2) A current director and a nominee for election as a director.
 
    In addition, options  to purchase 260,000  shares have been  granted to  all
current  executive officers as a group;  options to purchase 140,000 shares have
been granted to all current directors who are not executive officers as a group;
and options to purchase an aggregate of 125,000 shares have been granted to  all
employees,  including  current officers  who are  not  executive officers,  as a
group. Furthermore, the following persons, in addition to Mr. Scott, have in the
past received five percent of the outstanding options: Michael W. Crow, a former
Chairman, received options to  purchase 200,000 shares at  an exercise price  of
$.30  per  share, which  options  were exercised  by  Mr. Crow,  and  options to
purchase 20,000 shares at  an exercise price of  $1.50 per share, which  options
expired  following Mr. Crow's resignation as  Chairman in July, 1994; and George
R. Pache, a former Chief Financial Officer, received options to purchase 200,000
shares at an exercise price of $3.75 per share, which options expired  following
Mr. Pache's resignation in January, 1995.
 
                                       11
<PAGE>
    THE  BOARD  OF  DIRECTORS  RECOMMENDS THAT  THE  SHAREHOLDERS  VOTE  FOR THE
APPROVAL OF THE 1993 STOCK OPTION PLAN.
 
                            INDEPENDENT ACCOUNTANTS
 
    The Board  of  Directors  has  selected  the  firm  of  Corbin  &  Wertz  as
independent  public  accountants of  the Company  for  the current  fiscal year.
Corbin & Wertz served  as independent public accountants  of the Company  during
fiscal  1995. The Board of  Directors expects that a  representative of Corbin &
Wertz will be present at the Annual Meeting and will be given the opportunity to
make a statement, if desired, and to respond to appropriate questions.
 
                                 OTHER MATTERS
 
    The Board of Directors knows  of no other matters  to be brought before  the
Annual Meeting. However, if other matters should come before the Annual Meeting,
it  is the intention  of each person  named in the  proxy to vote  such proxy in
accordance with his judgment on such matters.
 
                             SHAREHOLDER PROPOSALS
 
    Any proposals of security holders which are intended to be presented at next
year's Annual Meeting must be received by the Company at its principal executive
offices on or before December 9, 1996 in order to be considered for inclusion in
the Company's proxy materials relating to that meeting.
 
                                       12
<PAGE>
                                                                       EXHIBIT A
 
                         ADVANCED MATERIALS GROUP, INC.
                             1993 STOCK OPTION PLAN
 
    1.  PURPOSE OF THE PLAN.
 
    The  purpose of this  1993 Stock Option Plan  ("Plan") of Advanced Materials
Group, Inc. (formerly known  as Far West Ventures,  Inc.), a Nevada  corporation
("Company")  is to provide the Company with  a means of attracting and retaining
the  services  of  highly  motivated  and  qualified  key  employees  (including
officers),  directors  and  consultants. The  Plan  is intended  to  advance the
interests of the  Company by  affording to key  employees (including  officers),
directors  and consultants, upon  whose skill, judgment,  initiative and efforts
the Company is largely dependent for the successful conduct of its business,  an
opportunity  for investment in the Company  and the incentives inherent in stock
ownership in the Company. In addition, the Plan contemplates the opportunity for
investment in the Company  by employees of companies  that do business with  the
Company. For purposes of this Plan, the term Company shall include subsidiaries,
if any, of the Company.
 
    2.  LEGAL COMPLIANCE.
 
    It  is the intent of the Plan  that all options granted under it ("Options")
shall be either "Incentive Stock Options"  ("ISOs"), as such term is defined  in
Section  422  of the  Internal Revenue  Code  of 1986,  as amended  ("Code"), or
non-qualified stock options ("NQOs"); provided,  however, ISOs shall be  granted
only  to employees of the Company. An Option shall be identified as an ISO or an
NQO in writing in the document or documents evidencing the grant of the  Option.
All  Options that  are not  so identified as  ISOs are  intended to  be NQOs. In
addition, the Plan provides for the grant of NQOs to employees of companies that
do business with  the Company.  It is  the further intent  of the  Plan that  it
conform  in all respects with  the requirements of Rule  16b-3 of the Securities
and Exchange Commission under  the Securities Exchange Act  of 1934, as  amended
("Rule  16b-3"). To the extent that any aspect of the Plan or its administration
shall at any time be viewed as inconsistent with the requirements of Rule  16b-3
or,  in  connection with  ISOs,  the Code,  such aspect  shall  be deemed  to be
modified,  deleted  or  otherwise  changed  as  necessary  to  ensure  continued
compliance with such provisions.
 
    3.  NON-EXCLUSIVITY OF THE PLAN.
 
    Nothing  contained in the Plan is intended  to amend, modify, or rescind any
previously approved compensation plans, programs or options entered into by  the
Company.  This Plan shall be  construed to be in  addition to and independent of
any and all such  other arrangements. Neither  the adoption of  the Plan by  the
Board  nor the  submission of the  Plan to  the stockholders of  the Company for
approval shall  be  construed  as  creating any  limitations  on  the  power  or
authority  of the  Board to  adopt, with  or without  stockholder approval, such
additional or other compensation arrangements as the Board may from time to time
deem desirable.
 
    4.  ADMINISTRATION OF THE PLAN.
 
       4.1  PLAN COMMITTEE.
 
        The Plan shall be administered by a committee ("Committee"). The members
    of the  Committee shall  be appointed  from time  to time  by the  Board  of
    Directors  of the Company ("Board")  and shall consist of  not less than two
    (2) nor more than five (5) persons  who are not eligible to receive  Options
    under  the Plan and  who are not, and  have not at any  time within one year
    (except as provided in SECTION 4.6), been eligible to receive stock  options
    pursuant  to the Plan or the  terms of any other plan  of the Company or its
    affiliates. Such persons shall be directors of the Company.
 
                                      A-1
<PAGE>
       4.2  GRANTS OF OPTIONS BY THE COMMITTEE.
 
        In accordance  with  the  provisions  of the  Plan,  the  Committee,  by
    resolution,  shall select  those eligible persons  to whom  Options shall be
    granted ("Optionees");  shall determine  the  time or  times at  which  each
    Option  shall be  granted, whether  an Option is  an ISO  or an  NQO and the
    number of shares to be  subject to each Option; and  shall fix the time  and
    manner  in which the Option may be exercised, the Option exercise price, and
    the Option period.
 
    The Committee shall determine the form  of option agreement to evidence  the
foregoing  terms and conditions of each Option,  which need not be identical, in
the form provided for in SECTION 8. Such option agreement may include such other
provisions as the Committee may deem necessary or desirable consistent with  the
Plan, the Code and Rule 16b-3.
 
       4.3  COMMITTEE PROCEDURES.
 
        The Committee from time to time may adopt such rules and regulations for
    carrying  out the purposes of the Plan as it may deem proper and in the best
    interests of the Company. The Committee  shall keep minutes of its  meetings
    and records of its actions. A majority of the members of the Committee shall
    constitute  a quorum for  the transaction of any  business by the Committee.
    The Committee may act at  any time by an affirmative  vote of a majority  of
    those  members voting.  Such vote may  be taken  at a meeting  (which may be
    conducted in  person  or by  any  telecommunication medium)  or  by  written
    consent of Committee members without a meeting.
 
       4.4  FINALITY OF COMMITTEE ACTION.
 
        The  Committee shall  resolve all questions  arising under  the Plan and
    option agreements entered  into pursuant  to the  Plan. Each  determination,
    interpretation,  or other  action made  or taken  by the  Committee shall be
    final  and  conclusive  and  binding  on  all  persons,  including,  without
    limitation,  the Company,  its stockholders, the  Committee and  each of the
    members of  the  Committee,  and  the  directors,  officers,  employees  and
    consultants  of  the  Company,  including  Optionees  and  their  respective
    successors in interest.
 
       4.5  NON-LIABILITY OF COMMITTEE MEMBERS.
 
        No Committee member shall be liable for any action or determination made
    by him in good faith  with respect to the Plan  or any Option granted  under
    it.
 
       4.6  DIRECTOR NQOS.
 
           (a)  As of May  22, 1993, or on  the date of  their first election or
       appointment as  directors,  whichever  is later,  each  director  of  the
       Company  shall be automatically granted an  NQO to purchase 20,000 shares
       of the Company's Common Stock (as  defined in SECTION 6), and  thereafter
       on  each anniversary of their first  election or appointment as director,
       each director of  the Company shall  be automatically granted  an NQO  to
       purchase  10,000  shares of  the Company's  Common  Stock (as  defined in
       SECTION 6).
 
           (b) Except as expressly authorized by this SECTION 4.6, directors  of
       the  Company who are members of  the Committee are not otherwise eligible
       to participate in the Plan.
 
           (c) Upon  the grant  of an  NQO  to a  director, the  director  shall
       receive a written option agreement substantially in the form provided for
       in  SECTION 8.  Such director  shall not be  an "Optionee"  as defined in
       SECTION 4.2 of the Plan.
 
           (d) The exercise price for each NQO granted under this Section  shall
       be  one hundred percent  (100%) of the  Fair Market Value  (as defined in
       SECTION 9) of the Company's Common Stock (as defined in SECTION 6) on the
       date of grant as determined by the Committee pursuant to SECTION 9 of the
       Plan. Each NQO granted  under this Section  shall be for  a term of  five
       years  and  shall  be  subject  to  earlier  termination  as  hereinafter
       provided.
 
                                      A-2
<PAGE>
           (e) An NQO granted  under this Section may  be exercised in whole  or
       consecutive  installments,  cumulative  or  otherwise,  during  its term;
       provided, however, no NQO granted under this Section shall be exercisable
       before six (6) months after the date  of grant of such NQO. In  addition,
       NQOs granted under this Section are subject to the rights and obligations
       of  Optionees, as provided in SECTION  12 of the Plan; provided, however,
       that the "stock  swap feature"  provided for in  SECTION 12  of the  Plan
       shall be available with respect to all NQOs granted under this Section.
 
           (f)  NQOs granted under this Section shall be subject to the exercise
       and non-transferability terms of SECTION 15 of the Plan. In the event  of
       the  termination of service on the Board by the holder of any NQO granted
       under this Section, then the outstanding NQOs of such holder shall expire
       one year  after  such  termination,  or  their  stated  expiration  date,
       whichever occurs first.
 
           (g)  Notwithstanding SECTIONS 4.1 AND 7 of  the Plan, the grant of an
       NQO  under  this  Section  shall  not  disqualify  such  director  as   a
       disinterested  person  for  purposes  of serving  on  the  Committee. The
       Committee shall have no  power under SECTIONS  4.2 AND 8  of the Plan  to
       determine the grant or terms of NQOs under this Section, but shall retain
       its  general authority  under SECTION  4.4 of  the Plan  to interpret and
       administer the Plan; provided, however, that, to the extent  practicable,
       an  individual  member  of  the Committee  should  disqualify  himself or
       herself from participation on any question which is unique to his or  her
       NQOs.
 
    5.  BOARD POWER TO AMEND, SUSPEND, OR TERMINATE THE PLAN.
 
    The  Board may, from time to time, make  such changes in or additions to the
Plan as it  may deem proper  and in the  best interests of  the Company and  its
stockholders.  The Board  may also  suspend or terminate  the Plan  at any time,
without notice, and in its sole discretion.
 
    Notwithstanding the  foregoing, no  such  change, addition,  suspension,  or
termination  by  the Board  shall (i)  materially  impair any  option previously
granted under the Plan without the  express written consent of the optionee;  or
(ii)  materially increase the  number of shares subject  to the Plan, materially
increase the benefits accruing  to optionees under  the Plan, materially  modify
the  requirements as  to eligibility  to participate  in the  Plan or  alter the
method of determining the option exercise price described in SECTION 9,  without
stockholder approval.
 
    6.  SHARES SUBJECT TO THE PLAN.
 
    For  purposes of the Plan, the Committee  is authorized to grant Options for
up to 1,250,000 shares  of the Company's common  stock ("Common Stock"), or  the
number and kind of shares of stock or other securities which, in accordance with
SECTION  14, shall be  substituted for such  shares of Common  Stock or to which
such shares shall  be adjusted.  The Committee  is authorized  to grant  options
under  the Plan with respect to such shares. Any or all unsold shares subject to
an Option which for any reason expires or otherwise terminates (excluding shares
returned to the Company in payment of the exercise price for additional  shares)
may again be made subject to grant under the Plan.
 
    7.  OPTIONEES.
 
    Options  shall be granted only to full-time elected or appointed officers or
other full-time key employees of the Company, to employees of companies that  do
business  with the Company  or to consultants  to the Company  designated by the
Committee from time to time as Optionees, including, without limitation, members
of the Board who  are also full-time  officers or key employees  at the time  of
grant.  In no event, however, may a member of the Committee be granted an Option
under the Plan. Any Optionee  may hold more than  one option to purchase  Common
Stock,  whether such option is an Option held pursuant to the Plan or otherwise.
An Optionee who is an employee of the Company
 
                                      A-3
<PAGE>
("Employee Optionee") and who holds an  Option must remain a continuous full  or
part-time  employee of the Company  from the time of grant  of the Option to him
until the time of its exercise, except as provided in SECTION 11.3.
 
    8.  GRANTS OF OPTIONS.
 
    The Committee shall have the sole discretion to grant Options under the Plan
and to determine whether  any Option shall be  an ISO or an  NQO. The terms  and
conditions  of Options granted under the Plan may differ from one another as the
Committee, in its absolute  discretion, shall determine as  long as all  Options
granted  under the Plan satisfy the requirements of the Plan. Upon determination
by the Committee  that an  Option is  to be granted  to an  Optionee, a  written
option  agreement  evidencing  such  Option  shall  be  given  to  the Optionee,
specifying the  number of  shares subject  to the  Option, the  Option  exercise
price,  whether the Option is  an ISO or an NQO,  and the other individual terms
and conditions of such Option.  Such option agreement may incorporate  generally
applicable  provisions from the Plan,  a copy of which  shall be provided to all
Optionees at the time of their initial  grants under the Plan. The Option  shall
be  deemed  granted as  of the  date specified  in the  grant resolution  of the
Committee, and  the option  agreement shall  be dated  as of  the date  of  such
resolution.
 
    9.  OPTION EXERCISE PRICE.
 
    The  price  per share  to be  paid by  the Optionee  at the  time an  ISO is
exercised shall not be less than one  hundred percent (100%) of the Fair  Market
Value  (as hereinafter defined) of one share of the optioned Common Stock on the
date on which the Option is granted. No ISO may be granted under the Plan to any
person who, at  the time  of such  grant, owns  (within the  meaning of  Section
424(d)  of the Code) stock  possessing more than ten  percent (10%) of the total
combined voting power of all  classes of stock of the  Company or of any  parent
thereof,  unless the exercise price of such ISO is at least equal to one hundred
and ten percent (110%) of Fair Market Value on the date of grant. The price  per
share  to be paid by the  Optionee at the time an  NQO is exercised shall not be
less than eighty-five  percent (85%) of  the Fair  Market Value on  the date  on
which the NQO is granted, as determined by the Committee.
 
    For  purposes  of  the Plan,  the  "Fair Market  Value"  of a  share  of the
Company's Common Stock as of a given date  shall be: (i) the closing price of  a
share of the Company's Common Stock on the principal exchange on which shares of
the Company's Common Stock are then trading, if any, on such date, or, if shares
were  not traded  on such date,  then on  the next preceding  trading day during
which a sale occurred; or (ii) if the Company's Common Stock is not traded on an
exchange but is quoted on NASDAQ or  a successor quotation system, (1) the  last
sales price (if the Common Stock is then listed as a National Market Issue under
the   NASD  National  Market  System)  or  (2)  the  mean  between  the  closing
representative bid and asked prices (in all other cases) for the Common Stock on
such date as reported by NASDAQ or such successor quotation system; or (iii)  if
the  Company's Common Stock is not publicly traded on an exchange and not quoted
on NASDAQ or a successor quotation system, the mean between the closing bid  and
asked  prices for the Common  Stock on such date as  determined in good faith by
the Committee; or (iv) if the Company's Common Stock is not publicly traded, the
fair market  value  established  by  the Committee  acting  in  good  faith.  In
addition, with respect to any ISO, the Fair Market Value on any given date shall
be  determined  in  a  manner  consistent with  any  regulations  issued  by the
Secretary of the Treasury  for the purpose of  determining fair market value  of
securities subject to an ISO plan under the Code.
 
    10.  CEILING OF ISO GRANTS.
 
    The  aggregate Fair Market Value (determined at the time any ISO is granted)
of the Common  Stock with  respect to which  an Optionee's  ISOs, together  with
incentive  stock options  granted under  any other plan  of the  Company and any
parent, are exercisable for the first time by such Optionee during any  calendar
year  shall  not exceed  $100,000.  In the  event  that an  Optionee  holds such
incentive stock options that become first exercisable (including as a result  of
acceleration of exercisability under the Plan) in any one year for shares having
a Fair Market Value at the date of grant
 
                                      A-4
<PAGE>
in  excess of  $100,000, then  the most  recently granted  of such  ISOs, to the
extent that they  are exercisable  for shares  having an  aggregate Fair  Market
Value in excess of such limit, shall be deemed to be NQOs.
 
    11.  DURATION, EXERCISABILITY, AND TERMINATION OF OPTIONS.
 
       11.1  OPTION PERIOD.
 
        The  option period shall be determined  by the Committee with respect to
    each Option granted. In no event, however, may the option period exceed  ten
    (10)  years from the date on which the  Option is granted, or five (5) years
    in the case of a grant of an ISO  to an Optionee who is a ten percent  (10%)
    shareholder  at the  date on  which the  Option is  granted as  described in
    SECTION 9.
 
       11.2  EXERCISABILITY OF OPTIONS AND ACCELERATION OF EXERCISABILITY.
 
        Each  Option  shall   be  exercisable   in  whole   or  in   consecutive
    installments,  cumulative or otherwise, during its term as determined in the
    discretion  of  the  Committee;  provided,  however,  no  Option  shall   be
    exercisable before six (6) months after the date of grant of such Option.
 
    Notwithstanding  the  foregoing,  the Committee  at  the time  of  grant may
provide that the  vesting of the  right to  exercise a given  Option or  portion
thereof  may be accelerated, during the term of the Option, under one or more of
the following circumstances: (i) if the Common Stock of the Company shall be the
subject of a tender  offer by any  person other than the  Company which, by  its
terms, could result in the offerer acquiring more than twenty-five percent (25%)
of  the then outstanding shares  of Common Stock of the  Company, or (ii) if the
shareholders shall consider, or be  asked to consider, merging or  consolidating
the  Company with any other person, or  transferring all or substantially all of
its assets to any other person, or (iii) if more than twenty-five percent  (25%)
of the Company's then outstanding voting shares shall be purchased by any person
other  than  the Company,  such that  granted but  unexercisable Options  may be
exercised at any  time following the  first public announcement  of such  event;
provided,  however, that in no  event shall an option  be exercised prior to six
months after the date of grant or beyond its stated term.
 
       11.3  TERMINATION OF OPTIONS DUE TO TERMINATION OF EMPLOYMENT,
             DISABILITY, OR DEATH OF OPTIONEE; TERMINATION FOR "CAUSE", OR
             RESIGNATION IN VIOLATION OF AN EMPLOYMENT AGREEMENT.
 
        All Options  granted  under the  Plan  to any  Employee  Optionee  shall
    terminate and may no longer be exercised if the Employee Optionee ceases, at
    any time during the period between the grant of the Option and its exercise,
    to be an employee of the Company; provided, however, the Committee may alter
    the termination date of the Option if the Optionee transfers to an affiliate
    of the Company.
 
    Notwithstanding  the foregoing,  (i) if  the Employee  Optionee's employment
with the Company shall  have terminated for any  reason (other than  involuntary
dismissal  for "cause" or voluntary resignation in violation of any agreement to
remain in the  employ of the  Company, including, without  limitation, any  such
agreement  pursuant to SECTION 16), he may, at any time before the expiration of
three (3) months  after such  termination or  before expiration  of the  Option,
whichever  shall first occur, exercise the Option (to the extent that the Option
was exercisable by him on the date  of the termination of his employment);  (ii)
if  the Employee Optionee's  employment shall have  terminated due to disability
(as defined  in Section  22(e)(3)  of the  Code and  subject  to such  proof  of
disability  as the Committee may  require), such Option may  be exercised by the
Employee Optionee  (or by  his guardian(s),  or conservator(s),  or other  legal
representative(s))  before  the  expiration  of twelve  (12)  months  after such
termination or before expiration of the Option, whichever shall first occur  (to
the extent that the Option was exercisable by him on the date of the termination
of his employment); (iii) in the event of the death of the Employee Optionee, an
Option  exercisable by him at the date of  his death shall be exercisable by his
legal representative(s),  legatee(s),  or  heir(s), or  by  his  beneficiary  or
beneficiaries  so designated by him as permitted  by SECTION 15, as the case may
be, within twelve (12)
 
                                      A-5
<PAGE>
months after his death or before  the expiration of the Option, whichever  shall
first occur (to the extent that the Option was exercisable by him on the date of
his  death); and  (iv) if the  Employee Optionee's employment  is terminated for
"cause" or in violation of any agreement to remain in the employ of the Company,
including, without limitation,  any such  agreement pursuant to  SECTION 16,  he
may,  at  any  time  before  the  expiration  of  thirty  (30)  days  after such
termination or before the expiration of the Option, whichever shall first occur,
exercise the Option (to the extent that the Option was exercisable by him on the
date of termination of  his employment). For purposes  of the Plan, "cause"  may
include,  without limitation, any illegal or  improper conduct (1) which injures
or impairs  the reputation,  goodwill, or  business of  the Company;  (2)  which
involves  the misappropriation of funds  of the Company, or  the misuse of data,
information, or documents acquired in connection with employment by the Company;
or (3) which violates any other directive or policy promulgated by the  Company.
A  termination for "cause"  may also include any  resignation in anticipation of
discharge for "cause" or resignation accepted by the Company in lieu of a formal
discharge for "Cause."
 
    12.  MANNER OF OPTION EXERCISE; RIGHTS AND OBLIGATIONS OF OPTIONEES.
 
       12.1  WRITTEN NOTICE OF EXERCISE.
 
        An Optionee may elect to  exercise an Option in  whole or in part,  from
    time  to time, subject to the terms and conditions contained in the Plan and
    in the  agreement  evidencing  such  Option, by  giving  written  notice  of
    exercise to the Company at its principal executive office.
 
       12.2  CASH PAYMENT FOR OPTIONED SHARES.
 
        If  an Option is exercised for cash, such notice shall be accompanied by
    a cashier's or personal check, or  money order, made payable to the  Company
    for the full exercise price of the shares purchased.
 
       12.3  STOCK SWAP FEATURE.
 
        At the time of the Option exercise, and subject to the discretion of the
    Committee to accept payment in cash only, the Optionee may determine whether
    the  total purchase price of the shares to be purchased shall be paid solely
    in cash  or by  transfer from  the  Optionee to  the Company  of  previously
    acquired  shares of Common Stock, or by  a combination thereof. In the event
    that the Optionee elects to pay the total purchase price in whole or in part
    with previously  acquired  shares  of  Common  Stock,  and  subject  to  the
    discretion  of the Committee  to accept payment  in cash only,  the value of
    such shares  shall be  equal  to their  Fair Market  Value  on the  date  of
    exercise,   determined  by  the  Committee  in  the  same  manner  used  for
    determining Fair Market Value at the  time of grant for purposes of  SECTION
    9.
 
       12.4  INVESTMENT REPRESENTATION FOR NON-REGISTERED SHARES AND LEGALITY OF
             ISSUANCE.
 
        The  receipt of shares  of Common Stock  upon the exercise  of an Option
    shall be conditioned upon  the Optionee (or any  other person who  exercises
    the  Option on his or her behalf  as permitted by SECTION 11.3) providing to
    the Committee a written representation that,  at the time of such  exercise,
    it is the intent of such person(s) to acquire the shares for investment only
    and  not with a  view toward distribution.  The certificate for unregistered
    shares issued  for investment  shall  be restricted  by  the Company  as  to
    transfer  unless the Company receives an  opinion of counsel satisfactory to
    the Company to the effect that such restriction is not necessary under  then
    pertaining  law. The providing of  such representation and such restrictions
    on transfer shall  not, however, be  required upon any  person's receipt  of
    shares  of Common  Stock under the  Plan in the  event that, at  the time of
    grant of the Option relating to such receipt or upon such receipt, whichever
    is the  appropriate measure  under applicable  federal or  state  securities
    laws,  the shares subject to the Option shall be (i) covered by an effective
    and current  registration statement  under the  Securities Act  of 1933,  as
    amended,  and  (ii)  either  qualified or  exempt  from  qualification under
    applicable state  securities  laws. The  Company  shall, however,  under  no
    circumstances  be required to sell or issue any shares under the Plan if, in
    the opinion of the Committee, (i) the
 
                                      A-6
<PAGE>
    issuance of such shares would constitute a violation by the Optionee or  the
    Company  of any applicable law or  regulation of any governmental authority,
    or (ii) the  consent or approval  of any governmental  body is necessary  or
    desirable  as a condition  of, or in  connection with, the  issuance of such
    shares.
 
       12.5  STOCKHOLDER RIGHTS OF OPTIONEE.
 
        Upon exercise,  the Optionee  (or  any other  person who  exercises  the
    Option  on his behalf as permitted by SECTION 11.3) shall be recorded on the
    books of the  Company as  the owner  of the  shares, and  the Company  shall
    deliver  to such  record owner  one or  more duly  issued stock certificates
    evidencing such ownership. No person shall have any rights as a  stockholder
    with  respect to  any shares  of Common Stock  covered by  an Option granted
    pursuant to  the Plan  until such  person shall  have become  the holder  of
    record  of such  shares. Except  as provided  in SECTION  14, no adjustments
    shall be made for cash dividends  or other distributions or other rights  as
    to  which there is a record date  preceding the date such person becomes the
    holder of record of such shares.
 
       12.6  HOLDING PERIODS FOR TAX PURPOSES.
 
        The Plan does not  provide that an Optionee  must hold shares of  Common
    Stock  acquired under the Plan for any minimum period of time. Optionees are
    urged to  consult  with their  own  tax advisors  with  respect to  the  tax
    consequences to them of their individual participation in the Plan.
 
    13.  SUCCESSIVE GRANTS.
 
    Successive grants of Options may be made to any Optionee under the Plan.
 
    14.  ADJUSTMENTS.
 
    If  the outstanding Common Stock shall  be hereafter increased or decreased,
or changed into or exchanged for a  different number or kind of shares or  other
securities   of  the   Company  or  ofanother   corporation,  by   reason  of  a
recapitalization, reclassification, reorganization, merger, consolidation, share
exchange, or other business  combination in which the  Company is the  surviving
parent  corporation, stock split-up, combination of shares, or dividend or other
distribution payable  in  capital stock  or  rights to  acquire  capital  stock,
appropriate  adjustment shall be made by the Committee in the number and kind of
shares for  which  options may  be  granted under  the  Plan. In  addition,  the
Committee  shall make appropriate adjustment in the number and kind of shares as
to which outstanding and  unexercised options shall be  exercisable, to the  end
that the proportionate interest of the holder of the option shall, to the extent
practicable,  be  maintained  as  before  the  occurrence  of  such  event. Such
adjustment in outstanding  options shall  be made  without change  in the  total
price   applicable  to  the  unexercised  portion  of  the  option  but  with  a
corresponding adjustment in the exercise price per share.
 
    In the  event  of  the  dissolution  or  liquidation  of  the  Company,  any
outstanding  and unexercised options shall  terminate as of a  future date to be
fixed by the Committee.
 
    In the event of a Reorganization (as hereinafter defined), then,
 
        a.  If there is no plan or agreement with respect to the  Reorganization
    ("Reorganization  Agreement"), or  if the Reorganization  Agreement does not
    specifically provide for the adjustment, change, conversion, or exchange  of
    the  outstanding  and  unexercised options  for  cash or  other  property or
    securities of  another corporation,  then  any outstanding  and  unexercised
    options shall terminate as of a future date to be fixed by the Committee; or
 
        b.    If there  is a  Reorganization  Agreement, and  the Reorganization
    Agreement specifically provides for  the adjustment, change, conversion,  or
    exchange  of  the  outstanding and  unexercised  options for  cash  or other
    property or  securities of  another corporation,  then the  Committee  shall
    adjust  the shares under such outstanding and unexercised options, and shall
    adjust the shares remaining under the Plan which are then available for  the
    issuance of options under the Plan if
 
                                      A-7
<PAGE>
    the Reorganization Agreement makes specific provisions therefor, in a manner
    not inconsistent with the provisions of the Reorganization Agreement for the
    adjustment, change, conversion, or exchange of such options and shares.
 
    The  term  "Reorganization"  as  used  in this  SECTION  14  shall  mean any
reorganization,  merger,  consolidation,  share  exchange,  or  other   business
combination   pursuant  to  which  the  Company  is  not  the  surviving  parent
corporation after the effective date of the Reorganization, or any sale or lease
of all or substantially all of the  assets of the Company. Nothing herein  shall
require  the Company to  adopt a Reorganization Agreement,  or to make provision
for the  adjustment, change,  conversion, or  exchange of  any options,  or  the
shares subject thereto, in any Reorganization Agreement which it does adopt.
 
    The Committee shall provide to each optionee then holding an outstanding and
unexercised  option not  less than thirty  (30) calendar  days' advanced written
notice of any date fixed by the Committee pursuant to this SECTION 14 and of the
terms of  any Reorganization  Agreement providing  for the  adjustment,  change,
conversion,  or exchange of  outstanding and unexercised  options. Except as the
Committee may otherwise provide, each optionee shall have the right during  such
period to exercise his option only to the extent that the option was exercisable
on the date such notice was provided to the optionee.
 
    Any  adjustment to any outstanding ISO pursuant  to this SECTION 14, if made
by reason of a  transaction described in  Section 424(a) of  the Code, shall  be
made  so as to conform  to the requirements of  that Section and the regulations
thereunder. If any  other transaction described  in Section 424(a)  of the  Code
affects  the Common  Stock subject  to any  unexercised ISO  theretofore granted
under the Plan (hereinafter for purposes of  this SECTION 14 referred to as  the
"old  option"), the  Board of Directors  of the  Company or of  any surviving or
acquiring  corporation  may  take  such  action  as  it  deems  appropriate,  in
conformity  with  the  requirements of  that  Code Section  and  the regulations
thereunder, to substitute a new option for the old option, in order to make  the
new option, as nearly as may be practicable, equivalent to the old option, or to
assume the old option.
 
    No  modification, extension, renewal, or other  change in any option granted
under the  Plan  may be  made,  after the  grant  of such  option,  without  the
optionee's  consent, unless the same is permitted  by the provisions of the Plan
and the option agreement. In  the case of an  ISO, optionees are hereby  advised
that  certain changes may disqualify the ISO from being considered as such under
Section 422 of the Code, or constitute a modification, extension, or renewal  of
the ISO under Section 424(h) of the Code.
 
    All  adjustments and determinations  under this SECTION 14  shall be made by
the Committee in good faith in its sole discretion.
 
    15.  NON-TRANSFERABILITY OF OPTIONS.
 
    An Option shall be exercisable only by the Optionee, or in the event of  his
disability,    by    his   guardian(s),    conservator(s),   or    other   legal
representative(s), during the Optionee's lifetime. In the event of the death  of
the  Optionee, an  Option shall be  exercisable by  his legal representative(s),
legatee(s), or heir(s),  as the  case may  be, or by  such person(s)  as he  may
designate  as his beneficiary or beneficiaries in a signed statement included as
a part of the option agreement.
 
    No Option  shall be  transferable  by the  Optionee, either  voluntarily  or
involuntarily,  except  by  will or  the  laws  of descent  and  distribution or
pursuant to a qualified domestic relations order as defined by the Code or Title
I of the Employee Retirement Income Security Act, or the rules thereunder.
 
    Any attempt to exercise, transfer or otherwise dispose of an interest in  an
Option  in contravention  of the  terms and  conditions of  the Plan,  or of the
option agreement for the Option, shall immediately void the Option.
 
                                      A-8
<PAGE>
    16.  CONTINUED EMPLOYMENT.
 
    As determined in the sole discretion of  the Committee at the time of  grant
and  if so stated in a writing signed by  the Company, each Option may have as a
condition the requirement of an Employee Optionee to remain in the employ of the
Company, or of its affiliates, and to render to it his or her exclusive service,
at such compensation as may be determined from time to time by it, for a  period
not  to  exceed  the term  of  the  Option, except  for  earlier  termination of
employment by or with the express written  consent of the Company or on  account
of  disability or death. The  failure of any Employee  Optionee to abide by such
agreement as to any Option under the  Plan may result in the termination of  all
of his or her then outstanding Options granted pursuant to the Plan.
 
    Neither  the creation  of the  Plan nor the  granting of  Option(s) under it
shall be  deemed  to  create  a  right in  an  Employee  Optionee  to  continued
employment  with the Company, and each such Employee Optionee shall be and shall
remain subject to discharge  by the Company  as though the  Plan had never  come
into  existence.  Except  as  specifically  provided  by  the  Committee  in any
particular case, the  loss of existing  or potential profit  in options  granted
under  this Plan  shall not  constitute an  element of  damages in  the event of
termination of  the employment  of an  employee even  if the  termination is  in
violation  of  an obligation  of  the Company  to  the employee  by  contract or
otherwise.
 
    17.  TAX WITHHOLDING.
 
    The exercise  of  any  option granted  under  the  Plan is  subject  to  the
condition  that if at any  time the Company shall  determine, in its discretion,
that the satisfaction of withholding tax or other withholding liabilities  under
any  federal, state or local law is necessary or desirable as a condition of, or
in connection with, such exercise or a later lapsing of time or restrictions  on
or  disposition of the shares of Common  Stock received upon such exercise, then
in such event, the  exercise of the  option shall not  be effective unless  such
withholding  shall have been effected or obtained  in a manner acceptable to the
Company. When an optionee is required to  pay to the Company an amount  required
to  be withheld under applicable income tax laws in connection with the exercise
of any option, the optionee may, subject to the approval of the Committee, which
approval shall not have been disapproved at any time after the election is made,
satisfy the obligation, in  whole or in  part, by electing  to have the  Company
withhold  shares of Common Stock having a  value equal to the amount required to
be withheld. The  value of the  Common Stock withheld  pursuant to the  election
shall  be determined by the Committee, in accordance with the criteria set forth
in SECTION 9, with  reference to the date  the amount of tax  to be withheld  is
determined  ("Tax Determination Date"). The optionee shall pay to the Company in
cash any  amount required  to be  withheld that  would otherwise  result in  the
withholding of a fractional share. The election by an optionee who is a director
or  officer of the  Company within the  meaning of Section  16 of the Securities
Exchange Act  of  1934,  as amended  ("Section  16  of the  1934  Act"),  to  be
effective, must meet all of the following requirements: (i) the election must be
made  on  or  prior  to  Tax  Determination  Date;  (ii)  the  election  must be
irrevocable; (iii) the exercise of an option may only be made six months or more
subsequent to the  grant of that  option (except that  this limitation will  not
apply  in the  event death  or disability  of the  optionee occurs  prior to the
expiration of the six-month period); and  (iv) the election must be made  either
(a)  six months  or more prior  to the Tax  Determination Date, or  (b) within a
ten-day "window  period"  beginning on  the  third business  day  following  the
release  of the  Company's annual  or quarterly  summary statement  of sales and
earnings and  ending on  the twelfth  business day  following the  date of  such
release.  Where  the Tax  Determination Date  of  a director  or officer  of the
Company within the meaning of Section 16  of the 1934 Act is deferred until  six
months  after exercise and that  director or officer elects  to have the Company
withhold shares pursuant to  the terms of  this SECTION 17,  the full amount  of
option shares shall be issued or transferred to him upon exercise but he will be
unconditionally obligated to tender back to the Company on the Tax Determination
Date  the  proper  number  of  shares of  Common  Stock  to  satisfy withholding
requirements, plus cash for any fractional amount.
 
                                      A-9
<PAGE>
    18.  TERM OF PLAN.
 
       18.1  EFFECTIVE DATE.
 
        Subject to  shareholder approval,  the Plan  shall become  effective  on
    April 1, 1993.
 
       18.2  TERMINATION DATE.
 
        Except  as to options previously granted and outstanding under the Plan,
    the Plan shall terminate at midnight on April 30, 2002, and no Option  shall
    be  granted after  that time.  Options then  outstanding may  continue to be
    exercised in  accordance with  their terms.  The Plan  may be  suspended  or
    terminated at any earlier time by the Board within the limitations set forth
    in SECTION 5.
 
    19.  GOVERNING LAW.
 
    The  Plan and  all rights  and obligations under  it shall  be construed and
enforced in accordance with the laws of the State of California.
 
                                      A-10
<PAGE>
                         ADVANCED MATERIALS GROUP, INC.
                    PROXY FOR ANNUAL MEETING OF STOCKHOLDERS
                           TO BE HELD ON MAY 8, 1996
 
    The  undersigned  hereby  constitutes and  appoints  Steve F.  Scott  and J.
Douglas Graven as  attorneys and proxies  and each  of them with  full power  of
substitution,  to attend  and vote  all of the  shares which  the undersigned is
entitled to vote  at the Annual  Meeting of Stockholders  of Advanced  Materials
Group, Inc. (the "Company") to be held at                   at 10:00 a.m., local
time,  on May  8, 1996 and  at any and  all adjournments thereof,  with the same
force and  effect  as  if  the undersigned  were  personally  present,  and  the
undersigned  hereby instructs said attorneys and proxies to vote as follows with
respect to the matters described in the Proxy Statement:
 
1. To elect five members of the Company's Board of Directors. The following five
   persons have been  nominated to serve  on the Company's  Board of  Directors:
   William  J. Hopke, Steve  F. Scott, Allan  H. Meltzer, N.  Price Paschall and
   Michael Ledeen.
 
   / /  FOR all nominees listed above  / /  WITHHOLD AUTHORITY to  vote for  all
                                            nominees listed above
 
- --------------------------------------------------------------------------------
 
    (Instructions: To withhold authority to vote for any one or more individual
                                   nominees,
        write the name of each such nominee on the line provided above.)
 
2. To reapprove the Company's 1993 Stock Option
Plan.               / /  FOR              / /  AGAINST              / /  ABSTAIN
 
3.  To transact such other  business as may properly  come before the meeting or
any adjournment or adjournments thereof.
 
                         (Please sign on reverse side)
<PAGE>
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF THE COMPANY WHICH
RECOMMENDS A VOTE FOR ITEMS 1 AND 2.  AS TO ANY OTHER MATTER WHICH MAY  PROPERLY
COME  BEFORE THE MEETING, SAID  PROXIES WILL VOTE IN  ACCORDANCE WITH THEIR BEST
JUDGMENT.
 
THIS PROXY when properly executed will  be voted in the manner directed  herein.
If no direction is given, the proxy will be voted FOR Items 1 and 2 herein.
                                              DATED: ____________________ , 1996
                                              __________________________________
                                                          (Signature)
                                              __________________________________
                                                          (Signature)
 
                                              NOTE:  Please sign exactly as your
                                              name or names appear on this card.
                                              Joint  owners  should  each   sign
                                              personally.    When   signing   as
                                              attorney, executor, administrator,
                                              personal  representative,  trustee
                                              or guardian, please give your full
                                              title  as such. (Please sign, date
                                              and  return  this  proxy  in   the
                                              enclosed envelope).


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission